Re: 'Efficacy and Safety of the New Oral Anticoagulants Dabigatran, Rivaroxaban, Apixaban, and Edoxaban in the Treatment and Secondary Prevention of Venous Thromboembolism: A Systematic Review and Meta-analysis of Phase III Trials'- Key Learning Points for Surgeons

Eur J Vasc Endovasc Surg. 2015 Jul;50(1):126-7. doi: 10.1016/j.ejvs.2015.02.022. Epub 2015 Apr 29.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anticoagulants / therapeutic use*
  • Benzimidazoles / therapeutic use*
  • Humans
  • Morpholines / therapeutic use*
  • Pyrazoles / therapeutic use*
  • Pyridines / therapeutic use*
  • Pyridones / therapeutic use*
  • Secondary Prevention*
  • Thiazoles / therapeutic use*
  • Thiophenes / therapeutic use*
  • Venous Thromboembolism / drug therapy*
  • beta-Alanine / analogs & derivatives*

Substances

  • Anticoagulants
  • Benzimidazoles
  • Morpholines
  • Pyrazoles
  • Pyridines
  • Pyridones
  • Thiazoles
  • Thiophenes
  • beta-Alanine